Frontiers in Cellular and Infection Microbiology

OCT 19, 2026 · JOURNAL ARTICLE

Metagenomic next-generation sequencing of matched donor–recipient pairs reveals pathogen transmission dynamics and informs antimicrobial therapy in liver transplantation: a retrospective cohort study

Frontiers in Cellular and Infection Microbiology

Background Post-transplant infections remain a leading cause of morbidity and mortality after liver transplantation (LT). Conventional microbiological culture has well-recognized l

OCT 16, 2026 · JOURNAL ARTICLE

Targeting the gut–tumor axis: probiotic therapy as an adjunct strategy in colorectal cancer treatment

Frontiers in Cellular and Infection Microbiology

Background Colorectal cancer (CRC) is a multifactorial disease driven by interactions among host genetics, immune dysregulation, environmental factors, and gut microbiota. The gut–

OCT 16, 2026 · JOURNAL ARTICLE

Upgrading the HIV vaccine paradigm: accounting for host-pathogen diversity through geotargeting-based vaccine design

Frontiers in Cellular and Infection Microbiology

Introduction Effective HIV vaccine development, with satisfactory levels of response and coverage, remains an elusive goal in immunology. In this context, considerations of host-pa

OCT 15, 2026 · JOURNAL ARTICLE

Mass cytometry of early immune remodeling after mRNA booster vaccination reveals exploratory CD4 naive T-cell associations with documented breakthrough infection

Frontiers in Cellular and Infection Microbiology

Background Messenger RNA (mRNA) vaccines rapidly engage innate and adaptive immunity, but the systemic immune changes occurring within 24 h of vaccination remain incompletely under

OCT 12, 2026 · JOURNAL ARTICLE

Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders

Frontiers in Cellular and Infection Microbiology

The gut microbiota is a taxonomically, genetically, and metabolically diverse and dynamic community of different microbial groups, including bacteria, archaea, fungi, and viruses,

OCT 8, 2026 · JOURNAL ARTICLE

Leishmaniasis and vaccine development: current progress, challenges, and future perspectives

Frontiers in Cellular and Infection Microbiology

Leishmaniasis remains one of the most important neglected tropical diseases (NTDs), affecting millions of individuals across tropical and subtropical regions. Caused by protozoan p

OCT 8, 2026 · JOURNAL ARTICLE

Diethyl fumarate exhibits potent activity against differentially culturable Mycobacterium tuberculosis persisters

Frontiers in Cellular and Infection Microbiology

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains the leading cause of death from a single infectious agent. During infection, Mtb forms drug-tolerant persiste

OCT 6, 2026 · JOURNAL ARTICLE

Prospects of pathogen whole-genome sequencing in outbreak tracing and antimicrobial resistance surveillance of spinal infections

Frontiers in Cellular and Infection Microbiology

Spinal infections are a serious category of deep-seated infectious diseases that pose significant threats to human health. They are caused by a broad and complex spectrum of pathog